Compare market size and growth of key Healthcare markets

Compare market size and growth of key Healthcare markets

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Loading...

Categories

11 Mexico Hyperglycemics Reports

Latin America Biguanide Industry

Country Covered: Mexico

Study Period: 2018 - 2029

Major Players: Bristol-Myers Squibb, Boehringer Ingelheim, Merck and Co., Sanofi Aventis, Glenmark Pharmaceuticals

Latin America Human Insulin Drugs Industry

Country Covered: Mexico

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Pfizer

Latin America Meglitinide Industry

Country Covered: Mexico

Study Period: 2018 - 2029

Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon

Meglitinides Market

Country Covered: Mexico

Study Period: 2019- 2029

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

SGLT2 Inhibitors Market

Country Covered: Mexico

Study Period: 2019 - 2029

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Fibrate Drugs Market

Country Covered: Mexico

Study Period: 2019 - 2029

Major Players: Abbott, Sanofi , Mylan Inc, Lupin, Aurobindo Pharma

Glargine Insulin Market

Country Covered: Mexico

Study Period: 2018 - 2029

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar

Basal Insulin (Long-Acting Insulin) Market

Country Covered: Mexico

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Insulin Market

Country Covered: Mexico

Study Period: 2019 - 2029

Major Players: Novo Nordisk A/S, Eli Lilly and Company, Pfizer Inc., Sanofi, Biocon

Sulfonylureas Industry

Country Covered: Mexico

Study Period: 2019- 2029

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

Biguanides Market

Country Covered: Mexico

Study Period: 2018 - 2029

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.